Concepedia

Tijl Huijbregts

TH

2

Publications

370

Citations

2

H-Index

2014

Active since

Affiliations

Synthon (Netherlands)(Current)

Tijl Huijbregts is an author at Synthon (Netherlands) specializing in drug discovery, drug development, and antibody engineering.

Top concepts

MedicinePharmacologyDrug DiscoveryDrug DevelopmentNatural SciencesMolecular BiologyAntibody EngineeringImmunologyImmunotherapyTumor Biology

Publications per year

2014–2015

2

Publications

2

Design, Synthesis, and Evaluation of Linker-Duocarmycin Payloads: Toward Selection of HER2-Targeting Antibody–Drug Conjugate SYD985

Ronald C. Elgersma, Ruud G. E. Coumans, Tijl Huijbregts et al. · Molecular Pharmaceutics · 2015 · 214 citations · Full text

Molecular Biology, Duocarmycin 3B, Pharmaceutical Chemistry +16

Preclinical Profile of the HER2-Targeting ADC SYD983/SYD985: Introduction of a New Duocarmycin-Based Linker-Drug Platform

Wim H.A. Dokter, Ruud Ubink, Miranda van der Lee et al. · Molecular Cancer Therapeutics · 2014 · 156 citations · Full text

Drug Target, Immunology, Molecular Biology +18

Rows per page

1–2 of 2